The effect of enamel matrix proteins and deproteinized bovine bone mineral on heterotopic bone formation.
To evaluate the osteoinductive potential of deproteinized bovine bone mineral (DBBM) and an enamel matrix derivative (EMD) in the muscle of rats. Sixteen rats were used in this study. The animals were divided in three groups. Group A: a pouch was created in one of the pectoralis profundis muscles of the thorax of the rats and DBBM particles (Bio-Oss) were placed into the pouch. Healing: 60 days. Group B: a small pouch was created on both pectoralis profundis muscles at each side of the thorax midline. In one side, a mixture of EMD (Emdogain) mixed with DBBM was placed into one of the pouches, whereas in the contralateral side of the thorax the pouch was implanted with DBBM mixed with the propylene glycol alginate (PGA--carrier for enamel matrix proteins of EMD). Healing: 60 days. Group C: the same procedure as group B, but with a healing period of 120 days. Qualitative histological analysis of the results was performed. At 60 days, the histological appearance of the DBBM particles implanted alone was similar to that of the particles implanted together with EMD or PGA at both 60 and 120 days. The DBBM particles were encapsulated into a connective tissue stroma and an inflammatory infiltrate. At 120 days, the DBBM particles implanted together with EMD or PGA exhibited the presence of resorption lacunae in some cases. Intramuscular bone formation was not encountered in any group. The implantation of DBBM particles alone, combined with EMD or its carrier (PGA) failed to exhibit extraskeletal, bone-inductive properties.
Donos
Nikolaos
N
Eastman Dental Institute, UCL, Department of Periodontology, London, UK. n.donos@eastman.ucl.ac.uk
Kostopoulos
Lambros
L
Tonetti
Maurizio
M
Karring
Thorkild
T
Lang
Niklaus P
NP
D000818:Animals; D018786:Bone Substitutes / Q000494:pharmacology*; D002417:Cattle; D003746:Dental Enamel Proteins / Q000494:pharmacology*; D008903:Minerals / Q000494:pharmacology*; D009132:Muscles / Q000187:drug effects; D009135:Muscular Diseases / Q000209:etiology; D009999:Ossification, Heterotopic / Q000209:etiology; D010012:Osteogenesis / Q000502:physiology*; D051381:Rats; D017208:Rats, Wistar
C077540:Bio-Oss; D018786:Bone Substitutes; D003746:Dental Enamel Proteins; D008903:Minerals; C109069:enamel matrix proteins